ZACHARY HATCH: Open Payments
NPI 1467730614 · SANTA PAULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 25 payments from 6 companies in 2025. Trend: 2023 $813 · 2024 $660 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $118 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Tris Pharma Inc | 1 | $25 |
| Alkermes, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Dyanavel XR, LYBALVI, Auvelity.
Industry payments across CA — which companies pay providers there.
